School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Ron Feldman

  • Department of Dermatology
    Associate Professor
  • ron.j.feldman@emory.edu
Head shot of Ron Feldman

Overview

Ron Feldman, MD PhD is an associate professor of Dermatology at the Emory University School of Medicine with a joint appointment at the Veterans Administration (VA) in Atlanta.

Dr. Feldman earned his Doctor of Medicine and Philosophy from the Medical University of South Carolina. He then completed a Dermatology Research Residency at Cleveland Clinic followed by a clinical fellowship in Autoimmune Blistering Diseases in Boston.

Dr. Feldman has extensive experience in treating patients with rare Autoimmune Blistering Diseases and receives referrals from all over Georgia and the Southeast United States. He runs a translational research program for 1) improving understanding and therapeutics for patients, 2) analyzing disease and treatment specific effects on patient quality of life, and 3) exploring immunological mechanisms involved in alteration of cellular adhesion. His research is supported by grants from the National Institutes of Health, Corporate collaborations and Private philanthropy.

Dr. Feldman is a Fellow of the American Academy of Dermatology and holds memberships in the Medical Dermatology Society, Society for Investigative Dermatology and the Atlanta Association for Dermatology and Dermatologic Surgery.

Academic Appointment

  • Associate Professor, Dermatology, Emory University School of Medicine

Education

Degrees

  • BS from College of Charleston
  • PhD from Medical University of South Carolina
  • MD from Medical University of South Carolina
  • Dermatology Residency from Cleveland Clinic

Research

Publications

  • The Impact of Air Pollution on Disease Activity in Bullous Pemphigoid and Pemphigus.
    JID Innov Volume: 5 Page(s): 100334
    05/01/2025 Authors: Feldman R; Cole EF
  • Clinical Observational Study Utilizing Teledermatology in Bullous Pemphigoid.
    J Invest Dermatol
    03/18/2025 Authors: Osuoji O; Adkins T; Barron J; Chen Y; Yue S; Liu Y; Stokes J; Bradley B; Chen S; Yeung H
  • Exploring Pruritus in Bullous Pemphigoid: Analysis of QOL Metrics and Potential Biological Mechanisms.
    JID Innov Volume: 5 Page(s): 100329
    03/01/2025 Authors: Osuoji OC; DeGrazia T; Rolader R; Cole EF; Lawson K; Hilley H; Xing Y; Han L; Chisolm S; Claussen H
  • Pemphigus-Associated Desmoglein-Specific IgG1 and IgG4 Have a Dominant Agalactosylated Glycan Modification.
    J Invest Dermatol Volume: 144 Page(s): 2584 - 2587.e6
    11/01/2024 Authors: Oloumi A; Le ST; Liu Y; Herbert S; Ji-Xu A; Merleev AA; Kruglinskaya O; Artounian K; Park D; Marusina AI
  • The safety of topical vs. oral steroids in bullous pemphigoid: considerations for retrospective analyses.
    Br J Dermatol Volume: 191 Page(s): 479 - 480
    09/18/2024 Authors: Amber KT; Feldman RJ
  • HIV-related exclusion criteria in atopic dermatitis and prurigo nodularis clinical trials.
    J Am Acad Dermatol Volume: 91 Page(s): 352 - 354
    08/01/2024 Authors: Leibowitz R; Fischer A; Collins LF; Feldman RJ; Yeung H
  • Disease severity and hospitalization risk factors in a cohort of Hispanic/Latino pemphigus patients: A descriptive retrospective chart review.
    J Am Acad Dermatol Volume: 90 Page(s): 1306 - 1308
    06/01/2024 Authors: Leibowitz R; Seely M; Holms LR; Mustin D; Guo R; Feldman RJ; Marano AL
  • Comparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus.
    J Drugs Dermatol Volume: 23 Page(s): e97 - e99
    03/01/2024 Authors: Mustin DE; Cole EF; Leibowitz R; Feldman RJ
  • Autoimmune encephalitis associated with autoimmune blistering diseases: A case series and retrospective review.
    JAAD Case Rep Volume: 37 Page(s): 92 - 97
    07/01/2023 Authors: Tadros AR; Atteh G; Vargas DL; Cole EF; Feldman RJ
  • New-Onset Pemphigoid Gestationis Following COVID-19 Vaccination.
    Cutis Volume: 111 Page(s): E2 - E4
    05/01/2023 Authors: Mustin DE; Huffaker TB; Feldman RJ
  • An oral lesion masquerading as lichen planus.
    Dermatol Online J Volume: 29
    04/15/2023 Authors: Mustin DE; Wetzel SL; Feldman RJ
  • The effect of skin colour and Fitzpatrick skin type on Bullous Pemphigoid Disease Area Index (BPDAI) scores.
    Br J Dermatol Volume: 187 Page(s): 606 - 607
    10/01/2022 Authors: Cole EF; Mustin DE; Feldman RJ
  • Single Center Retrospective Study of Patients with Ocular Mucous Membrane Pemphigoid (MMP).
    Ocul Immunol Inflamm Volume: 30 Page(s): 256 - 261
    01/02/2022 Authors: Morel M; DeGrazia T; Ward L; Behshad S; Kim HJ; Feldman R
  • Dupilumab-induced erythema nodosum.
    JAAD Case Rep Volume: 19 Page(s): 41 - 43
    01/01/2022 Authors: Mustin DE; Cole EF; Blalock TW; Kuruvilla ME; Stoff BK; Feldman RJ
  • Assessing Disease Outcome Measures in Bullous Pemphigoid on Standard-Of-Care Therapies.
    JID Innov Volume: 1 Page(s): 100050
    12/01/2021 Authors: Cole EF; DeGrazia T; Sun Y; Liu Y; Feldman RJ
  • Entropion repair outcomes in ocular cicatricial pemphigoid versus other cicatricial etiologies: A retrospective study
    Volume: 141 Page(s): S64 - S64
    05/01/2021 Authors: Braun HA; Schaffer L; Cole EF; Risk B; Kim H; Feldman R
  • Bullous eczema presenting as bullous pemphigoid-like eruption: A case series.
    JAAD Case Rep Volume: 10 Page(s): 34 - 37
    04/01/2021 Authors: Atteh G; Cole EF; Perricone AJ; Feldman RJ
  • Cross-sectional study of the prevalence and predictors of pruritus in pemphigus as compared with bullous pemphigoid
    Volume: 83 Page(s): AB139 - AB139
    12/01/2020 Authors: Rolader R; Daugherty LN; Liu Y; Feldman RJ
  • Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
    Exp Dermatol Volume: 29 Page(s): 1191 - 1198
    12/01/2020 Authors: Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R
  • APPLICATION OF IPSC-DERIVED AIRWAY EPITHELIUM FOR EVALUATING THE RESPONSE OF RARE OR UNKNOWN CFTR MUTATIONS TO MODULATORS
    Volume: 55 Page(s): S193 - S193
    10/01/2020 Authors: Barilla C; Suzuki S; Rab A; Goller K; Hong JS; Driggers WC; Flores J; Feldman RJ; Solomon GM; Stecenko A
  • IMPROVED FUNCTIONAL RESCUE OF G551D CFTR BY TRIPLE COMBINATION THERAPY
    Volume: 55 Page(s): S188 - S189
    10/01/2020 Authors: Rab A; Suzuki S; Disha J; Barilla C; Goller K; Manfredi C; Flores JK; Streby A; Stecenko A; Feldman RJ
  • Comparative analysis of pruritus and intraepidermal nerve fiber density in atopic dermatitis and bullous pemphigoid
    Volume: 140 Page(s): S21 - S21
    07/01/2020 Authors: DeGrazia TM; Cole EM; Xing Y; Hilley H; Han L; Chisolm S; Chen SC; Feldman R
  • Prevalence and predictors of pruritus in pemphigus compared with bullous pemphigoid: A cross-sectional study.
    J Am Acad Dermatol Volume: 83 Page(s): 251 - 254
    07/01/2020 Authors: Rolader R; Daugherty LN; Liu Y; Feldman RJ
  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts.
    J Am Acad Dermatol Volume: 82 Page(s): 575 - 585.e1
    03/01/2020 Authors: Murrell DF; Pea S; Joly P; Marinovic B; Hashimoto T; Diaz LA; Sinha AA; Payne AS; Daneshpazhooh M; Eming R
  • Updates on diagnosis and management of autoimmune blistering diseases.
    G Ital Dermatol Venereol Volume: 155 Page(s): 46 - 64
    02/01/2020 Authors: Cole EF; Sami N; Feldman RJ
  • Bilateral keratoprostheses in a patient with ocular mucous membrane pemphigoid.
    Dermatol Online J Volume: 25
    11/15/2019 Authors: DeGrazia T; Bromley J; Feldman R
  • Mucous Membrane Pemphigoid Presenting With Esophageal Manifestations: A Case Series.
    Am J Gastroenterol Volume: 114 Page(s): 1695 - 1697
    10/01/2019 Authors: DeGrazia T; Eisenstadt R; Willingham FF; Feldman R
  • Itch and quality of life impact in atopic dermatitis vs bullous pemphigoid
    Volume: 139 Page(s): B14 - B14
    09/01/2019 Authors: DeGrazia TM; Liu Y; Bradley B; Thompson C; Francois S; Chisolm S; Chen SC; Feldman RJ
  • Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune Disease.
    Cell Rep Volume: 28 Page(s): 909 - 922.e6
    07/23/2019 Authors: Cho A; Caldara AL; Ran NA; Menne Z; Kauffman RC; Affer M; Llovet A; Norwood C; Scanlan A; Mantus G
  • Rituximab therapy in patients with bullous pemphigoid: A retrospective study of 20 patients.
    J Am Acad Dermatol Volume: 81 Page(s): 179 - 186
    07/01/2019 Authors: Polansky M; Eisenstadt R; DeGrazia T; Zhao X; Liu Y; Feldman R
  • Leukotriene B4 pathway and tissue damage markers are expressed by granulocytes in lesional skin in bullous pemphigoid
    Volume: 139 Page(s): S179 - S179
    05/01/2019 Authors: Margaroli C; Bradley B; Bhatt L; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
  • Pemphigus vulgaris patient disease severity correlates with in vitro assessments of desmosomal function
    Volume: 139 Page(s): S75 - S75
    05/01/2019 Authors: Caldara AL; Warren MF; Cho A; Zimmer SE; Feldman RJ; Swerlick R; Wrammert J; Kowalczyk AP
  • Comparative analysis of quality of life impact in patients with autoimmune blistering disease
    Volume: 139 Page(s): S99 - S99
    05/01/2019 Authors: Alshamekh S; DeGrazia TM; Chen SC; Liu Y; Feldman R
  • Autoimmune Sequelae Following Rituximab Therapy: A Review of the Literature and Potential Immunologic Mechanisms.
    J Clin Rheumatol Volume: 24 Page(s): 427 - 435
    12/01/2018 Authors: Kersh AE; Feldman RJ
  • TRAVEL-RELATED LEISHMANIASIS AND TUMOUR NECROSIS FACTOR INHIBITORS: 2 CASES OF MISDIAGNOSIS
    Volume: 66 Page(s): 468 - 468
    02/01/2018 Authors: Rabold E; Feldman RJ; Lutgring J; Moanna A; Wu H
  • Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab.
    J Am Acad Dermatol Volume: 77 Page(s): 1074 - 1082
    12/01/2017 Authors: Albers LN; Liu Y; Bo N; Swerlick RA; Feldman RJ
  • Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone.
    JAMA Dermatol Volume: 153 Page(s): 1018 - 1020
    10/01/2017 Authors: Albers LN; Arbiser JL; Feldman RJ
  • Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab.
    JCI Insight Volume: 2
    06/15/2017 Authors: Cho A; Bradley B; Kauffman R; Priyamvada L; Kovalenkov Y; Feldman R; Wrammert J
  • Dynamic biomarkers to predict relapse in pemphigus patients treated with rituximab
    Volume: 137 Page(s): S9 - S9
    05/01/2017 Authors: Albers L; Liu Y; Bo N; Swerlick R; Feldman R
  • Rituximab Treatment for Recalcitrant Dermatitis Herpetiformis.
    JAMA Dermatol Volume: 153 Page(s): 315 - 318
    03/01/2017 Authors: Albers LN; Zone JJ; Stoff BK; Feldman RJ
  • Autoimmune blistering diseases associated with parotid mucoepidermoid carcinoma: A report of two cases
    Volume: 25 Page(s): 46 - 47
    11/01/2016 Authors: Albers L; Feldman R
  • Rituximab combined with conventional therapy vs conventional therapy alone for the treatment of mucous membrane pemphigoid: A retrospective review
    Volume: 74 Page(s): AB148 - AB148
    05/01/2016 Authors: Warren M; Maley A; Feldman R
  • Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    J Am Acad Dermatol Volume: 74 Page(s): 835 - 840
    05/01/2016 Authors: Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
  • Super-Resolution Microscopy Reveals Altered Desmosomal Protein Organization in Tissue from Patients with Pemphigus Vulgaris.
    J Invest Dermatol Volume: 136 Page(s): 59 - 66
    01/01/2016 Authors: Stahley SN; Warren MF; Feldman RJ; Swerlick RA; Mattheyses AL; Kowalczyk AP
  • Complete remission after rituximab therapy in an HIV-positive patient with pemphigus vulgaris.
    Br J Dermatol Volume: 173 Page(s): 1557 - 1559
    12/01/2015 Authors: Polansky M; Patel N; Feldman R
  • Super-Resolution Microscopy Reveals Altered Desmosomal Protein Organization in Pemphigus Vulgaris Patient Tissue.
    J Invest Dermatol
    09/09/2015 Authors: Stahley SN; Warren MF; Feldman RJ; Swerlick RA; Mattheyses AL; Kowalczyk AP
  • Paradoxical worsening of pemphigus vulgaris following rituximab therapy.
    Br J Dermatol Volume: 173 Page(s): 858 - 859
    09/01/2015 Authors: Feldman RJ
  • Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus.
    Nat Immunol Volume: 16 Page(s): 755 - 765
    07/01/2015 Authors: Tipton CM; Fucile CF; Darce J; Chida A; Ichikawa T; Gregoretti I; Schieferl S; Hom J; Jenks S; Feldman RJ
  • Altered desmosome organization, endocytosis and desmosome splitting in pemphigus vulgaris epidermis as revealed by super-resolution microscopy
    Volume: 135 Page(s): S82 - S82
    05/01/2015 Authors: Stahley SN; Warren M; Feldman RJ; Swerlick R; Mattheyses A; Kowalczyk A
  • B-cell profiling to predict clinical response following Rituximab therapy in patients with autoimmune blistering diseases
    Volume: 135 Page(s): S11 - S11
    05/01/2015 Authors: Booker S; Bradley B; Neary B; Wei C; Sanz I; Feldman RJ
  • Responses to influenza vaccine after rituximab therapy in patients with autoimmune blistering diseases
    Volume: 135 Page(s): S8 - S8
    05/01/2015 Authors: Cho A; Bradley B; Priyamvada L; Kovalenkov Y; Feldman RJ; Wrammert J
  • Defining unique B cell signatures in patients with autoimmune blistering diseases
    Volume: 133 Page(s): S46 - S46
    05/01/2013 Authors: Feldman RJ; Wei C; Neary BE; Sanz I
  • UV protection and sunscreens: what to tell patients.
    Cleve Clin J Med Volume: 79 Page(s): 427 - 436
    06/01/2012 Authors: Jou PC; Feldman RJ; Tomecki KJ
  • Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.
    Br J Dermatol Volume: 166 Page(s): 511 - 517
    03/01/2012 Authors: Feldman RJ; Christen WG; Ahmed AR
  • Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3.
    J Invest Dermatol Volume: 132 Page(s): 198 - 207
    01/01/2012 Authors: Mack JA; Feldman RJ; Itano N; Kimata K; Lauer M; Hascall VC; Maytin EV
  • Relevance of rituximab therapy in pemphigus vulgaris: analysis of current data and the immunologic basis for its observed responses.
    Expert Rev Clin Immunol Volume: 7 Page(s): 529 - 541
    07/01/2011 Authors: Feldman RJ; Ahmed AR
  • INFLAMMATION AFTER SKIN INJURY IS ENHANCED IN HYALURONAN SYNTHASE (HAS1/HAS3) DOUBLE KNOCKOUT MICE
    WOUND REPAIR AND REGENERATION Volume: 19 Page(s): A36 - A36
    03/01/2011 Authors: Mack JA; Feldman RJ; Maytin EV
  • PDEF is a negative regulator of colon cancer cell growth and migration.
    J Cell Biochem Volume: 108 Page(s): 1389 - 1398
    12/15/2009 Authors: Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
  • Upregulation of hyaluronan synthases during phorbol ester (TPA)-induced hyperplasia with potential functional compensation by Has2 in Has1/Has3 double knockout mice
    Volume: 129 Page(s): S75 - S75
    04/01/2009 Authors: Feldman R; Monslow J; Itano N; Kimata K; Maytin E
  • Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
    J Invest Dermatol Volume: 127 Page(s): 2336 - 2344
    10/01/2007 Authors: D'Alessandro M; Coats SE; Morley SM; Mackintosh L; Tessari G; Turco A; Gerdes A-M; Pichert G; Whittaker S; Brandrup F
  • Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.
    Int J Dermatol Volume: 46 Page(s): 77 - 79
    01/01/2007 Authors: Feldman RJ; Maize JC
  • Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Cancer Res Volume: 63 Page(s): 4626 - 4631
    08/01/2003 Authors: Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
  • The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis.
    Anticancer Res Volume: 23 Page(s): 2125 - 2131
    01/01/2003 Authors: Feldman RJ; Sementchenko VI; Watson DK
  • In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues.
    Antimicrob Agents Chemother Volume: 43 Page(s): 2479 - 2483
    10/01/1999 Authors: Yoshimura K; Feldman R; Kodama E; Kavlick MF; Qiu YL; Zemlicka J; Mitsuya H
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information